The cost-effectiveness of Buccolam® (licensed oromucosal midazolam) for the treatment of acute epileptic seizures in the United Kingdom; A hybrid model solution

Authors:

Lee D, Batty A, Gladwell D, Brereton N and Tate E.

Publication Type:

Conference Proceedings – Poster

Publication Name:

15th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Lee D, Batty A, Gladwell D, Brereton N and Tate E. The cost-effectiveness of Buccolam® (licensed oromucosal midazolam) for the treatment of acute epileptic seizures in the United Kingdom; A hybrid model solution. 15th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Berlin, Germany. 3-7 November 2012. Poster PND37.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies